Titre : Ureohydrolases

Ureohydrolases : Questions médicales fréquentes

Termes MeSH sélectionnés :

Robotics
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Ureohydrolases : Questions médicales les plus fréquentes", "headline": "Ureohydrolases : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Ureohydrolases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-02", "dateModified": "2025-02-27", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Ureohydrolases" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Hydrolases", "url": "https://questionsmedicales.fr/mesh/D006867", "about": { "@type": "MedicalCondition", "name": "Hydrolases", "code": { "@type": "MedicalCode", "code": "D006867", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Arginase", "alternateName": "Arginase", "url": "https://questionsmedicales.fr/mesh/D001119", "about": { "@type": "MedicalCondition", "name": "Arginase", "code": { "@type": "MedicalCode", "code": "D001119", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.913.292" } } } ], "about": { "@type": "MedicalCondition", "name": "Ureohydrolases", "alternateName": "Ureohydrolases", "code": { "@type": "MedicalCode", "code": "D014512", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "M Sinn", "url": "https://questionsmedicales.fr/author/M%20Sinn", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, University of Konstanz, Konstanz, Germany. malte.sinn@uni-konstanz.de." } }, { "@type": "Person", "name": "L Riede", "url": "https://questionsmedicales.fr/author/L%20Riede", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, University of Konstanz, Konstanz, Germany." } }, { "@type": "Person", "name": "J R Fleming", "url": "https://questionsmedicales.fr/author/J%20R%20Fleming", "affiliation": { "@type": "Organization", "name": "Department of Biology, University of Konstanz, Konstanz, Germany." } }, { "@type": "Person", "name": "D Funck", "url": "https://questionsmedicales.fr/author/D%20Funck", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, University of Konstanz, Konstanz, Germany." } }, { "@type": "Person", "name": "H Lutz", "url": "https://questionsmedicales.fr/author/H%20Lutz", "affiliation": { "@type": "Organization", "name": "Department of Biology, University of Konstanz, Konstanz, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Initial Experience of Single-Port Robotic Lobectomy for Large-Sized Non-Small Cell Lung Cancer: A Single-Center Retrospective Study.", "datePublished": "2024-09-05", "url": "https://questionsmedicales.fr/article/39272949", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/cancers16173091" } }, { "@type": "ScholarlyArticle", "name": "A novel pelvis-prostate model BPPP predicts immediate urinary continence after Retzius-sparing robotic-assisted laparoscopic radical prostatectomy.", "datePublished": "2024-08-20", "url": "https://questionsmedicales.fr/article/39164347", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-70080-8" } }, { "@type": "ScholarlyArticle", "name": "Features related to temporary tracheotomy in patients undergoing Transoral Robotic Surgery (TORS) for supraglottic squamous cell cancer of the larynx: A systematic review.", "datePublished": "2024-07-25", "url": "https://questionsmedicales.fr/article/39068815", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.amjoto.2024.104436" } }, { "@type": "ScholarlyArticle", "name": "Win ratio analysis of short-term clinical outcomes of focal therapy and robot-assisted radical prostatectomy for the patients with localized prostate cancer.", "datePublished": "2024-07-24", "url": "https://questionsmedicales.fr/article/39043819", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-67592-8" } }, { "@type": "ScholarlyArticle", "name": "Postoperative Complications and Readmission Rates in Robotic-Assisted Versus Manual Total Knee Arthroplasty: Large, Propensity Score-Matched Patient Cohorts.", "datePublished": "2024-07-19", "url": "https://questionsmedicales.fr/article/39029449", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.5435/JAAOS-D-23-01117" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Enzymes et coenzymes", "item": "https://questionsmedicales.fr/mesh/D045762" }, { "@type": "ListItem", "position": 3, "name": "Enzymes", "item": "https://questionsmedicales.fr/mesh/D004798" }, { "@type": "ListItem", "position": 4, "name": "Hydrolases", "item": "https://questionsmedicales.fr/mesh/D006867" }, { "@type": "ListItem", "position": 5, "name": "Ureohydrolases", "item": "https://questionsmedicales.fr/mesh/D014512" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Ureohydrolases - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Ureohydrolases", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-08", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Ureohydrolases", "description": "Comment diagnostiquer une déficience en ureohydrolases ?\nQuels tests sont utilisés pour évaluer l'activité des ureohydrolases ?\nQuels symptômes indiquent un problème avec les ureohydrolases ?\nLes tests génétiques sont-ils utiles pour les ureohydrolases ?\nComment l'historique médical aide-t-il au diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Robotics&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Ureohydrolases", "description": "Quels sont les symptômes d'une accumulation d'urée ?\nComment se manifeste une hyperammoniémie ?\nLes symptômes varient-ils selon l'âge ?\nQuels signes cliniques sont associés à une déficience en ureohydrolases ?\nPeut-on avoir des symptômes sans déficience enzymatique ?", "url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Robotics&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Ureohydrolases", "description": "Peut-on prévenir les troubles liés aux ureohydrolases ?\nLes conseils diététiques peuvent-ils prévenir ces troubles ?\nLe dépistage néonatal est-il recommandé ?\nLes antécédents familiaux influencent-ils la prévention ?\nLes vaccinations ont-elles un rôle dans la prévention ?", "url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Robotics&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Ureohydrolases", "description": "Quel est le traitement principal pour les troubles liés aux ureohydrolases ?\nLes médicaments peuvent-ils aider à gérer les symptômes ?\nLa dialyse est-elle une option de traitement ?\nLes thérapies nutritionnelles sont-elles efficaces ?\nY a-t-il des traitements expérimentaux pour ces troubles ?", "url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Robotics&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Ureohydrolases", "description": "Quelles complications peuvent survenir avec une hyperammoniémie ?\nLes troubles du comportement sont-ils une complication ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles réversibles ?\nLes complications peuvent-elles survenir à tout âge ?", "url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Robotics&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Ureohydrolases", "description": "Quels sont les facteurs de risque pour les troubles des ureohydrolases ?\nL'alimentation joue-t-elle un rôle dans les facteurs de risque ?\nLes infections peuvent-elles aggraver les troubles ?\nLes facteurs environnementaux influencent-ils ces troubles ?\nLes médicaments peuvent-ils être un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Robotics&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une déficience en ureohydrolases ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins et urinaires mesurant les niveaux d'urée et d'ammoniac sont effectués." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'activité des ureohydrolases ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests enzymatiques spécifiques et des analyses biochimiques sont utilisés." } }, { "@type": "Question", "name": "Quels symptômes indiquent un problème avec les ureohydrolases ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la confusion, la fatigue et des troubles neurologiques peuvent apparaître." } }, { "@type": "Question", "name": "Les tests génétiques sont-ils utiles pour les ureohydrolases ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent identifier des mutations génétiques liées à des déficiences enzymatiques." } }, { "@type": "Question", "name": "Comment l'historique médical aide-t-il au diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical peut révéler des antécédents familiaux de troubles métaboliques." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une accumulation d'urée ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des nausées, des vomissements, et des troubles de la conscience." } }, { "@type": "Question", "name": "Comment se manifeste une hyperammoniémie ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle se manifeste par des troubles neurologiques, des céphalées et des convulsions." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent être plus graves chez les nourrissons et les jeunes enfants." } }, { "@type": "Question", "name": "Quels signes cliniques sont associés à une déficience en ureohydrolases ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme l'irritabilité, la léthargie et des troubles de l'alimentation peuvent apparaître." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes sans déficience enzymatique ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, d'autres conditions médicales peuvent provoquer des symptômes similaires." } }, { "@type": "Question", "name": "Peut-on prévenir les troubles liés aux ureohydrolases ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention est difficile, mais un dépistage précoce peut aider à gérer les risques." } }, { "@type": "Question", "name": "Les conseils diététiques peuvent-ils prévenir ces troubles ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des conseils diététiques peuvent réduire le risque d'accumulation d'urée." } }, { "@type": "Question", "name": "Le dépistage néonatal est-il recommandé ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage néonatal peut identifier les troubles métaboliques précocement." } }, { "@type": "Question", "name": "Les antécédents familiaux influencent-ils la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de troubles peuvent justifier un suivi médical accru." } }, { "@type": "Question", "name": "Les vaccinations ont-elles un rôle dans la prévention ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Non, les vaccinations ne préviennent pas directement les troubles liés aux ureohydrolases." } }, { "@type": "Question", "name": "Quel est le traitement principal pour les troubles liés aux ureohydrolases ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement principal est une restriction protéique et des suppléments d'arginine." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider à gérer les symptômes ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des médicaments peuvent être prescrits pour réduire les niveaux d'ammoniac." } }, { "@type": "Question", "name": "La dialyse est-elle une option de traitement ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la dialyse peut être utilisée pour éliminer l'excès d'ammoniac dans les cas graves." } }, { "@type": "Question", "name": "Les thérapies nutritionnelles sont-elles efficaces ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une thérapie nutritionnelle adaptée peut aider à gérer les niveaux d'urée." } }, { "@type": "Question", "name": "Y a-t-il des traitements expérimentaux pour ces troubles ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements expérimentaux, comme la thérapie génique, sont en cours d'étude." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une hyperammoniémie ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications graves incluent des lésions cérébrales et des troubles neurologiques." } }, { "@type": "Question", "name": "Les troubles du comportement sont-ils une complication ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles du comportement peuvent survenir en raison de l'accumulation d'ammoniac." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent gravement affecter la qualité de vie et nécessiter des soins constants." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non." } }, { "@type": "Question", "name": "Les complications peuvent-elles survenir à tout âge ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications peuvent survenir à tout âge, mais sont plus fréquentes chez les jeunes." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les troubles des ureohydrolases ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des maladies métaboliques et des régimes inappropriés." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle dans les facteurs de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en protéines peut augmenter le risque d'accumulation d'urée." } }, { "@type": "Question", "name": "Les infections peuvent-elles aggraver les troubles ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections peuvent exacerber les symptômes et augmenter les niveaux d'ammoniac." } }, { "@type": "Question", "name": "Les facteurs environnementaux influencent-ils ces troubles ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs environnementaux comme la pollution peuvent affecter le métabolisme." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils être un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent interférer avec le métabolisme de l'urée et des enzymes." } } ] } ] }

Sources (10000 au total)

Features related to temporary tracheotomy in patients undergoing Transoral Robotic Surgery (TORS) for supraglottic squamous cell cancer of the larynx: A systematic review.

The aim of this systematic review is to assess a relation between demographical, clinical and tumoral features and the need for a prophylactic tracheotomy during TORS procedure in patients affected by... PRISMA 2020 guidelines were applied in this systematic literature review. A computerized search was performed using the Embase/Pubmed, Scopus and Cochrane database, for articles published from 2007 to... Through a study selection process 8 full texts were eligible for statistical univariate analysis. The most relevant factor related to a prophylactic tracheotomy was a contextual bilateral cervical nod... The prophylactic tracheotomy is considered a temporary protection strategy to achieve a valid recovery after TORS procedure. However, there are no guidelines regarding its routinely use. Only 25 % of ...

Win ratio analysis of short-term clinical outcomes of focal therapy and robot-assisted radical prostatectomy for the patients with localized prostate cancer.

We compared the comprehensive clinical outcomes of focal therapy (FT) and robot-assisted radical prostatectomy (RARP) in patients with localized prostate cancer (PC) using a win ratio analysis. After ...

Postoperative Complications and Readmission Rates in Robotic-Assisted Versus Manual Total Knee Arthroplasty: Large, Propensity Score-Matched Patient Cohorts.

There is a paucity of research comparing postoperative complication rates between manual total knee arthroplasty (M-TKA) and robotic-assisted total knee arthroplasty (RA-TKA). This study aims to compa... A retrospective review of a multihospital database identified patients who underwent TKA between January 2016 and May 2023. Surgeons who used the robotic-assisted surgery technique in <10% or >90% of ... All-cause 90-day readmission rates were 2.4% for RA-TKA and 2.6% for M-TKA (P = 0.36). RA-TKA had fewer revisits (RA-TKA: 7.8%; M-TKA: 8.8%, P = 0.027) and rates of readmission with >23 hours of obser... In this retrospective matched cohort analysis, RA-TKA was associated with markedly fewer revisits and readmissions with >23 hours of observation compared with M-TKA. No differences in all-cause 90-day... Level III.... Retrospective review....

Implementation and Validation of a High-Fidelity Simulation Model for Surgical Resident Training: Management of Acute Intraoperative Hemorrhage during Robot-assisted Surgery.

To improve our previous simulation-based training module by using sustainable material to mold an anatomically accurate terrain and reproducing major vascular injuries encountered during robot-assiste... The simulator was built with a pump, gauge, and valve linked via silicone tubing. Artificial blood was made from cornstarch, water, and red dye, and pumped through 3D-Med artificial vessels with the d... The apparatus demonstrated high reproducibility across all simulation scenarios, enhancing resident problem-solving skills. Residents' pre-simulation surveys revealed significant concern regarding the... The management of acute hemorrhage during robot-assisted surgery remains a space for additional surgical education and training. Our simulation successfully provided a reliable, reproducible training ...

Liver respiratory-induced motion estimation using abdominal surface displacement as a surrogate: robotic phantom and clinical validation with varied correspondence models.

This work presents the implementation of an RGB-D camera as a surrogate signal for liver respiratory-induced motion estimation. This study aims to validate the feasibility of RGB-D cameras as a surrog... The proposed approach uses an RGB-D camera to compute an abdominal surface reconstruction and estimate the liver respiratory-induced motion. Two sets of validation experiments were conducted, first, u... The motion model for the robotic liver phantom displayed an error below 3 mm with a coefficient of determination above 90% for the different directions of motion. The clinical study presented errors o... RGB-D cameras are a promising method to accurately estimate the liver respiratory-induced motion. The internal motion can be estimated in a non-contact, noninvasive and flexible approach. Additionally...

Is it safe to defer prostate cancer treatment? Assessing the impact of surgical delay on the risk of pathological upstaging after robot-assisted radical prostatectomy.

We sought to investigate whether surgical delay may be associated with pathological upstaging in patients treated with robot assisted radical prostatectomy (RARP) for localized and locally advanced pr... Consecutive firstly-diagnosed PCa patients starting from March 2020 have been enrolled. All the patients were categorized according to EAU risk categories for PCa risk. Uni- and multivariate analysis ... Overall 2017 patients entered the study. Median age at surgery was 68 (IQR 63-73) years. Overall low risk, intermediate risk, localized high risk and locally advanced disease were recorded in 368 (18.... In localized high-risk disease surgical delay could be associated with a higher risk of adverse pathologic findings....

Safety and oncological outcome of early intraoperative intravesicle mitomycin C vs. deferred instillation in patients receiving robot-assisted radical nephroureterectomy.

Radical nephroureterectomy with concurrent bladder cuff excision (RNUBCE) is the gold standard surgical approach for high-risk primary upper tract urothelial carcinoma (UTUC). Given the notably high i... This is a retrospective chart review study. Patients with non-invasive (N0, not T3/T4) UTUC who underwent robotic RNUBCE combined an intraoperative MMC instillation or a deferred MMC instillation afte... A total of 54 patients were included in the analysis. 12 (22.2%) patients experienced a bladder tumor recurrence during follow-up (IO: 7.7%, PO: 35.7%,... IIntraoperative MMC instillation is safe and associated with a lower bladder tumor recurrence risk in patients undergoing robotic RNUBCE for UTUC than deferred instillation. Future large, prospective ...